Report overview
This report contains market size and forecasts of Active Transdermal Drug Delivery Device in global, including the following market information:
Global Active Transdermal Drug Delivery Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Transdermal Drug Delivery Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Active Transdermal Drug Delivery Device companies in 2021 (%)
The global Active Transdermal Drug Delivery Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patches Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Transdermal Drug Delivery Device include Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., 3M, Actavis, Inc., Bayer AG and Boehringer Ingelheim GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Active Transdermal Drug Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Transdermal Drug Delivery Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, by Type, 2021 (%)
Patches
Gels
Global Active Transdermal Drug Delivery Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Home Use
Global Active Transdermal Drug Delivery Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Transdermal Drug Delivery Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Transdermal Drug Delivery Device revenues share in global market, 2021 (%)
Key companies Active Transdermal Drug Delivery Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Active Transdermal Drug Delivery Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
